Allmed Solutions

Minimally Invasive Advanced Medical Devices

Health Tech & Life Sciences
Public on TASE on Feb, 2007
Public Caesarea, Israel Founded 2001
Last updated 2026-06-18
Total raised
$3.4M
Last: pipe 2022-09
Stage
Public
Founded
2001
Headcount
23
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences

About

Allmed Solutions develops, manufactures, and markets minimally invasive products designed to benefit patients by improving and shortening the recovery process. The company's products are used by physicians to treat a wide range of diseases and patients worldwide.

Allmed Solutions currently markets three minimally invasive medical device product lines: an embolic protection device, urological and biliary stents, and pelvic organ prolapse repair devices. The company is also developing a gastro-duodenal sleeve for the treatment of type 2 diabetes and a mitral valve replacement.

Each of Allmed Solutions' product lines is operated by one its subsidiaries, all of which are located in the company's corporate headquarters and benefit from its collective engineering, operating, regulatory, clinical, and marketing infrastructure to support their respective activities.

Funding history · 1 round · $3.4M total

2022-09
pipe $3.4M

Q&A

What is Allmed Solutions' primary focus?
Allmed Solutions develops, manufactures, and markets minimally invasive advanced medical devices designed to improve and shorten patient recovery processes.
When was Allmed Solutions founded?
Allmed Solutions was founded in January 2001.
What is the current employee count for Allmed Solutions?
Allmed Solutions has an employee count in the 11-50 range.
When did Allmed Solutions become a public company?
Allmed Solutions became a public company on TASE in February 2007.
What was Allmed Solutions' most recent funding round?
In September 2022, Allmed Solutions completed a PIPE funding round, raising $3.4 million from investor.
What are some of Allmed Solutions' current product lines?
Allmed Solutions currently markets three minimally invasive medical device product lines: an embolic protection device, urological and biliary stents, and pelvic organ prolapse repair devices.
What new medical devices is Allmed Solutions developing?
Allmed Solutions is developing a gastro-duodenal sleeve for the treatment of type 2 diabetes and a mitral valve replacement.
Who are the key executives at Allmed Solutions?
The key executives at Allmed Solutions include Oz Shapira as CEO and Erez Keinan as CFO.

Team · 2

Oz Shapira
CEO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesPolymersImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

surgerydiabetesgastroenterologymedical-devicesgynecologyminimally-invasivemedical-productsurologycardiovascularstenthospitalscardiologypolymersdoctors
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)